13G Filing: Balyasny Asset Management and Sunesis Pharmaceuticals Inc (SNSS)

Page 2 of 30

Page 2 of 30 – SEC Filing


CUSIP No. 867328700 Page
2
of 30 Pages
  1 

NAMES OF
REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

Atlas Master Fund, Ltd.

  2

CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP*

(a)  ☐        (b)  ☐

  3

SEC USE ONLY

  4

CITIZENSHIP OR PLACE OF
ORGANIZATION

Cayman

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5   

SOLE VOTING POWER

224,506 (See Item 4)

6

SHARED VOTING POWER

None (See Item 4)

7

SOLE DISPOSITIVE POWER

224,506 (See Item 4)

8

SHARED DISPOSITIVE POWER

None

  9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

224,506 (See Item 4)

10

CHECK BOX IF THE AGGREGATE AMOUNT IN
ROW (9) EXCLUDES CERTAIN SHARES*  ☐

Not Applicable

11

PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW (9)

1.05%

12

TYPE OF REPORTING PERSON*

CO

* SEE INSTRUCTIONS BEFORE FILLING OUT.

Follow Viracta Therapeutics Inc. (NASDAQ:VIRX)

Page 2 of 30